A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation
June 8th, 2018
11K views
Irreversible electroporation (IRE) is a non-thermal ablation technique used for the treatment of locally advanced pancreatic cancer. Being a relatively new technique, the effects of IRE on the tumor growth are poorly understood. We have developed a syngeneic mouse model that facilitates studying the effects of IRE on pancreatic cancer.
Overview
This study focuses on irreversible electroporation (IRE), a non-thermal ablation technique for treating locally advanced pancreatic cancer. A syngeneic mouse model has been developed to investigate the effects of IRE on tumor growth and the local tumor microenvironment.
Key Study Components
Area of Science
- Neuroscience
- Oncology
- Immunology
Background
- IRE is a relatively new technique in cancer treatment.
- The effects of IRE on pancreatic cancer are not well understood.
- Understanding IRE's impact on the immune system is crucial.
- This study utilizes an immunocompetent mouse model for accurate assessments.
Purpose of Study
- To investigate how IRE affects the local tumor microenvironment.
- To assess the role of IRE in pancreatic cancer progression.
- To provide insights into the immune response to IRE treatment.
Methods Used
- Development of a syngeneic mouse model.
- Subcutaneous tumor induction in C57 black six mice.
- Assessment of tumor growth in an immunocompetent system.
- Analysis of IRE effects on the immune system.
Main Results
- The model allows for accurate tumor growth assessment.
- IRE influences the local tumor microenvironment.
- Insights into immune system interactions with IRE treatment.
- Potential implications for future pancreatic cancer therapies.
Conclusions
- IRE shows promise as a treatment for pancreatic cancer.
- The syngeneic mouse model is effective for studying IRE.
- Further research is needed to fully understand IRE's effects.
Frequently Asked Questions
What is irreversible electroporation?
Irreversible electroporation (IRE) is a non-thermal ablation technique used to destroy cancer cells.
How does IRE affect pancreatic cancer?
IRE's effects on pancreatic cancer are still being studied, particularly regarding tumor growth and the immune response.
What is a syngeneic mouse model?
A syngeneic mouse model uses genetically identical mice to study disease processes and treatment effects.
Why is an immunocompetent model important?
An immunocompetent model allows researchers to study the immune system's response to treatments like IRE without genetic modifications.
What are the advantages of using this model?
The model facilitates accurate tumor growth assessment and provides insights into the immune system's interactions with IRE.
What future research is needed?
Further studies are required to fully understand the implications of IRE on pancreatic cancer and the immune system.
Executive Industry Relevance
This syngeneic mouse model enables biopharma R&D to evaluate irreversible electroporation (IRE) in an immunocompetent pancreatic cancer system, providing mechanistic insights into tumor microenvironment changes and immune interactions. By supporting longitudinal studies post-ablation, the model aids in de-risking IRE as a monotherapy or in combination regimens, informing go/no-go decisions for preclinical advancement. The model’s reproducibility and scalability support preclinical validation workflows, reducing biological uncertainty in early-stage oncology pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of IRE-induced tumor microenvironment changes and immune cell infiltration in immunocompetent hosts.
- Operational Value: Provides a controlled system to assess biological effects of ablation without genetic manipulation.
Screening & Assay Development
- Scientific Value: Generates quantifiable tumor growth and necrosis readouts for dose-response and timing optimization.
- Operational Value: Standardizes ablation parameters (voltage, pulse frequency, duration) for reproducible preclinical testing.
Translational & Preclinical Research
- Scientific Value: Supports evaluation of IRE monotherapy and combination with radiation or chemotherapy in immunocompetent settings.
- Operational Value: Facilitates longitudinal monitoring of tumor regression and regrowth to inform therapeutic scheduling.
Pipeline & Workflow Integration
The model integrates into oncology discovery workflows by enabling hypothesis testing on ablation mechanisms, immune modulation, and combination therapy efficacy prior to lead identification.
- Discovery Biology: Tests how IRE alters tumor-stroma interactions and immune cell recruitment in syngeneic models.
- Screening: Delivers quantitative tumor volume and histological necrosis metrics for ablation parameter screening.
- Analytics: Provides immune profiling and histopathological outputs to correlate ablation intensity with biological response.
- Translational Research: Models orthotopic tumor response to IRE, enabling preclinical validation of locoregional ablation strategies.
- Enterprise Reuse: Adaptable to other solid tumor models for platform-wide ablation technology assessment.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking of IRE through immune and microenvironmental profiling in immunocompetent systems.
- Operational Value: Standardized surgical and ablation procedures reduce variability across studies and sites.
- Strategic Value: Informs combination therapy exploration by revealing windows of immune modulation post-ablation.
- Portfolio Impact: Enables risk-adjusted prioritization of IRE-based approaches by clarifying biological activity and limitations.
Implementation Considerations
- Requires expertise in murine orthotopic tumor implantation and sterile surgical techniques.
- Dependent on electroporator calibration and needle electrode array compatibility with tumor size.
- Necessitates standardized tumor measurement and histology protocols for cross-study comparability.
- Limited to tumors within electrode working distance; larger tumors may yield inconsistent ablation zones.
- Requires immune monitoring capacity to assess microenvironmental changes post-IRE.
Biopharma FAQs
Why does tumor size consistency matter for IRE delivery?
Tumor size must remain within the working distance of IRE electrodes to ensure complete ablation; larger tumors produce inconsistent responses due to incomplete treatment coverage, as noted in the procedural limitations.
How does immune monitoring add value in this immunocompetent model?
The model enables assessment of IRE’s effects on the immune system without genetic knockouts, providing insights into microenvironmental changes and immune cell recruitment post-ablation.
What quantitative outputs enable ablation parameter optimization?
Tumor growth rates, regression percentages, and histological necrosis measurements allow researchers to optimize voltage, pulse frequency, and duration for consistent biological effects.
Why are longitudinal studies post-IRE critical for combination therapy planning?
Monitoring tumor regrowth and immune dynamics after IRE reveals temporal windows when adjuvant therapies like radiation or chemotherapy may enhance efficacy.
What standardization is required for reproducible IRE experiments across sites?
Reproducibility depends on standardized tumor implantation, electrode placement, pulse delivery parameters, and post-procedure monitoring intervals to minimize variability in ablation outcomes.
